We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRMB icon
26
Trimble
TRMB
$12.3B
$119M 0.76%
1,366,385
-8,218
-0.6% -$706K
ON icon
27
ON Semiconductor
ON
$33.8B
$117M 0.75%
1,724,682
-22,957
-1% -$1.3M
GILD icon
28
Gilead Sciences
GILD
$161B
$115M 0.74%
1,586,713
+29,102
+2% +$2M
PANW icon
29
Palo Alto Networks
PANW
$264B
$113M 0.72%
1,223,076
-26,808
-2% -$2.32M
ABT icon
30
Abbott
ABT
$180B
$111M 0.71%
785,698
+204,459
+35% +$26.2M
CRM icon
31
Salesforce
CRM
$134B
$105M 0.67%
412,412
+32,176
+8% +$9.04M
HD icon
32
Home Depot
HD
$332B
$103M 0.66%
247,746
+275
+0.1% +$105K
DIS icon
33
Walt Disney
DIS
$165B
$103M 0.66%
663,307
+29,923
+5% +$4.83M
A icon
34
Agilent Technologies
A
$39.1B
$102M 0.65%
640,560
+24,704
+4% +$3.85M
AMD icon
35
Advanced Micro Devices
AMD
$851B
$102M 0.65%
710,262
+4,922
+0.7% +$662K
AMAT icon
36
Applied Materials
AMAT
$426B
$102M 0.65%
647,712
-444
-0.1% -$64.3K
RY icon
37
Royal Bank of Canada
RY
$291B
$101M 0.65%
951,781
-294,988
-24% -$30.6M
SBUX icon
38
Starbucks
SBUX
$118B
$99.9M 0.64%
853,817
+23,533
+3% +$2.65M
C icon
39
Citigroup
C
$222B
$93.1M 0.59%
1,542,034
+157,413
+11% +$10.5M
ILMN icon
40
Illumina
ILMN
$29.4B
$91.5M 0.58%
247,284
+17,375
+8% +$6.58M
TSM icon
41
TSMC
TSM
$2.09T
$90.4M 0.58%
751,261
-77,448
-9% -$9.07M
ROK icon
42
Rockwell Automation
ROK
$51.4B
$87.4M 0.56%
250,558
+6,125
+3% +$2.03M
HOLX
43
DELISTED
Hologic
HOLX
$87.2M 0.56%
1,139,174
+603,846
+113% +$44.4M
CSCO icon
44
Cisco
CSCO
$450B
$86.2M 0.55%
1,359,472
+541,538
+66% +$30.9M
QCOM icon
45
Qualcomm
QCOM
$176B
$83.3M 0.53%
455,480
-190,242
-29% -$30.5M
NKE icon
46
Nike
NKE
$61.9B
$82.3M 0.53%
493,549
-125,686
-20% -$20.7M
MA icon
47
Mastercard
MA
$477B
$80.6M 0.51%
224,370
+36,088
+19% +$12.5M
APD icon
48
Air Products & Chemicals
APD
$66.3B
$78.3M 0.5%
257,360
+1,063
+0.4% +$312K
EL icon
49
Estee Lauder
EL
$29B
$74.1M 0.47%
200,106
-1,281
-0.6% -$435K
SQM icon
50
Sociedad Química y Minera de Chile
SQM
$19.6B
$72.6M 0.46%
1,439,988
+100,533
+8% +$5.77M

Similar funds

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.